ZANE SAGHAIAN: Open Payments
NPI 1861039513 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$242 in 13 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $73 · 2025 $242
Food & beverage: $242
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 4 | $78 |
| Lilly USA, LLC | 3 | $52 |
| Phathom Pharmaceuticals, Inc. | 2 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
| Dexcom, Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: MOUNJARO, VOQUEZNA, BREZTRI, GIVLAARI, Dexcom G6 Transmitter, JARDIANCE.
Industry payments across CA — which companies pay providers there.
